Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial glycolytic enzymes are a group of metabolic proteins that catalyze each step of the **glycolysis pathway**—the process by which bacteria convert glucose into pyruvate with concomitant production of ATP and NADH. The canonical set includes hexokinase/glucokinase, phosphofructokinase, aldolase, triose phosphate isomerase, glyceraldehyde 3-phosphate dehydrogenase (GAPDH), phosphoglycerate kinase/mutase, enolase, and pyruvate kinase[5][7]. In bacteria such as *Escherichia coli*, these enzymes can have unique isoforms or regulatory mechanisms compared to eukaryotes[5][7]. In addition to their central role in energy production and carbon flux under both aerobic and anaerobic conditions[7], several bacterial glycolytic enzymes exhibit "moonlighting" functions unrelated to metabolism. For example, surface-exposed forms can bind host proteins like plasminogen or fibronectin—facilitating tissue invasion and immune evasion during infection[6][7]. This makes them potential targets for antimicrobial therapy or vaccine development. However, "Bacterial glycolytic enzyme" refers not to a single molecular entity but rather an entire class/family comprising multiple distinct proteins. As such it is **not a precise target name** suitable for structured drug discovery databases—it lacks specificity regarding which particular protein/enzyme is meant. Each member has its own gene/protein name (e.g., GAPDH [glyceraldehyde 3-phosphate dehydrogenase], PK [pyruvate kinase], etc.), structure-function relationships, inhibitor profiles and disease associations. Therefore: > The term “Bacterial glycolytic enzyme” describes an important family/class of metabolic targets involved in glucose breakdown within bacteria. While many members are validated therapeutic targets due to their essential roles in pathogen survival/virulence—and some have been explored individually—the phrase itself does not denote a single canonical molecule/receptor but rather an enzymatic category encompassing multiple distinct entities.[5][6][7] If you need information about a specific member—for example “Bacterial glyceraldehyde 3-phosphate dehydrogenase”—a more detailed entry can be provided. **Note:** This entry is marked **is_incorrect: true** because it refers generically to an entire enzymatic pathway/class rather than one defined molecular target suitable for structured annotation.[5][6]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial glycolytic enzyme.